CHM chimeric therapeutics limited

Fair play, mate. I’m the same, and that’s why I’m here....

  1. 8,252 Posts.
    lightbulb Created with Sketch. 3238
    Fair play, mate. I’m the same, and that’s why I’m here. Apologies if I came on a bit strong—not my intention.

    My real anger should be directed at the Paul Hoppers of the world. How do these guys keep getting away with it? His track record: IMU, RAD, CHM—all down over 90% since 2021. Meanwhile, he’s pocketing millions in salaries and “performance rights” (ironic right) from each. It’s a masterclass in coasting while shareholders take the hit.

    These execs shouldn’t have guaranteed million-dollar paychecks while the shareholders bleed out. Tie their incentives to the share price—make them sweat alongside us.

    And here’s the kicker: without that pressure, why would they take real risks? If they swing for the fences and fail, the gravy train of the millions in salaries for years derails. But if they slow-walk everything, string shareholders along with vague “updates,” and avoid decisive action for years? They can keep milking fat salaries, performance bonuses, and cushy roles for years which seems to be the whats happening.

    Why shoot for the moon when crawling keeps the money flowing? It’s a broken system, rewarding complacency and punishing shareholders. Unless this changes, we’re just funding luxury lifestyles while they dodge accountability.

    And before anyone says Hopper “having skin in the game” with his holdings, let’s be real—most of those shares were gifted to him for free. The silver lining? Shareholders are waking up. Look at the last vote:

    chmmeetingresults.png

    Almost 50% of votes rejected giving him more freebies! That’s progress.

    Now, to get out of the gloomy outlook, let’s be fair—if you look at CHM like it’s a brand-new company, it’s not all doom and gloom. Decent cash in the bank, trading at lows with a tiny market cap, and some potential catalysts to give a big re-rate on the horizon. If you’re starting fresh today, it actually looks like a solid opportunity.

    The downsides? High executive pay, a management team with a spotty history, and a knack for questionable raises. Plus, they’ll likely need more cash within the year, which isn’t exactly comforting because they wont be raising lower now, so if they want to raise would likely be a consolidation then a capital raise.

    It’s shaping up to be a fun one to watch.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $100 25K

Buyers (Bids)

No. Vol. Price($)
28 21874000 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 19510638 27
View Market Depth
Last trade - 15.25pm 17/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.